| NIDC: National Isotope Development Center

Join us for Spring Stakeholder Meetings!

The DOE IP invites you to join us for virtual "one-on-one" stakeholder meetings on May 28, and May 29, 2024. Plus, for those planning to attend the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto, Canada, we are pleased to announce one day of in-person stakeholder meetings on June 10, 2024.

Isotope Product Catalog

With 225+ isotopes available for purchase, the U.S. Department of Energy Isotope Program is the world leader in quality, purity, and availability of the most sought after and rare isotopes.

Go to Catalog

DOE Isotope Program and QSA Global Inc. partner for domestic production of iridium-192

The U.S. Department of Energy (DOE) Isotope Program and QSA Global Inc. announced a joint product development agreement to initiate domestic production of iridium-192 (Ir-192), a critical isotope for industrial gamma ray radiography.

DOE Isotope Program Welcomes Texas A&M University Cyclotron Institute to the University Isotope Network

The DOE Isotope Program is excited to announce the addition of the Texas A&M University Cyclotron Institute to the University Isotope Network. Supported by DOE and the State of Texas funding, the Cyclotron Institute has developed Astatine-211 (At-211) production which is now available for routine regional distribution through the NIDC product catalog. The…

Announcing domestic supply of lead-203

The U.S. Department of Energy Isotope Program is pleased to announce lead-203 (Pb-203) has been added to our catalog and is available for purchase. Pb-203 has drawn interest as a SPECT imaging isotope analogue to the therapeutic Pb-212, an alpha-emitter. Its addition to the NIDC Catalog establishes a theranostic matched pair of isotopes. Pb-203 will be shipped on a monthly basis with the…

SPECT image of 0.8 mCi of Pb-203 as PbCl2 in solution. The material was placed in a small device used to gauge resolution capabilities of the imaging camera against the source isotope. Image courtesy: Suzanne E. Lapi and Shefali Saini, UAB

Translating Research to Applications

Get a behind-the-scenes look at the production of isotopes across the Department's facilities that are critical to everyday applications, particularly in the medical arena.

View Video

Recordings Now Available: DOE IP Virtual Seminar Series

The DOE Isotope Program hosted three virtual seminars focused on the following emerging medical isotopes: astatine-211, lead-203/212, and cerium-134. If you were unable to attend, or want to watch it again, you can now access the meeting recordings and presentations for your convenience.

Medical Isotopes

With more than 35 medically relevant isotopes available and others under investigation, the NIDC is committed to supplying the world with the highest quality isotopes for medical use.

Download Brochure

Technical Resources

Need a custom service for your order? We offer a wide variety of special services to complement our radioactive and stable isotope offerings.

Technical Resources

Our mission is to support the U.S. Department of Energy Isotope Program as the global leader in the production and distribution of radioactive and enriched stable isotopes that are deemed critical or are in short supply.

About Us

NIDC News

DOE IP responds to elevated demand for cadmium-109

The U.S. Department of Energy Isotope Program has ramped up production of high specific activity cadmium-109 (Cd-109) to address a recent surge in demand as end users seek to diversify their supply chains.

Learn More

Join us for Spring Stakeholder Meetings!

The DOE IP invites you to join us for one-on-one stakeholder meetings on May 28, May 29, 2024, and June 10, 2024.

Learn More

U.S. DOE Announces RENEW Funding Opportunity

The DOE Isotope Program (DOE IP) is participating in the recently announced DOE Office of Science (SC) Reaching a New Energy Sciences Workforce (RENEW) initiative

Learn More

DOE Isotope Program Highlights

Image courtesy of Bobba, K.N., et al., Evaluation of cerium/lanthanum-134 as a PET imaging theranostic pair for 225Ac alpha radiotherapeutics. Journal of Nuclear Medicine 64, 7 (2023). Radiopharmaceuticals based on cerium/lanthanum-134 have promise for prostate cancer imaging and therapy. At right, tumors show high tumor uptake of cerium-134. At left, a comparison of cerium-134 and actinium-225 shows a similar pattern of uptake in most tissues (note the tumor tissue on the leg).

Transforming Cancer Diagnosis and Treatment with Cerium/Lanthanum-134

October 25, 2023

Researchers advance the use of cerium/lanthanum-134 for medical scans in actinium-225 cancer therapy.

Learn More

Image courtesy of Brookhaven National Laboratory Depiction of a titanium-44/scandium-44 generator. The generator consists of a hydroxamate-based resin undergoing scandium-44 elution with hydrochloric acid.

Scientists Identify an Alternative System for Producing the Medical Isotope Scandium-44

August 29, 2023

An easy-to-use system can increase the availability of PET imaging agents to more patients.

Learn More

This image depicts a binding molecule delivering radium-223 to a cancer cell. Image courtesy of Adam Malin, Oak Ridge National Laboratory.

Capturing the Chemistry of Radium-223 for Cancer Treatment

August 11, 2023

Until now, there have been few efforts to get information on how radium binds with known chelators.

Learn More

Image courtesy of Jonathan Engle, University of Wisconsin. Summary of the production process for radioisotopes of scandium using recyclable, enriched calcium.

Researchers Improve Production for Short-Lived Scandium Radioisotopes

August 1, 2023

Hard to produce in quantities and purities appropriate for human use, scandium radioisotopes have potential for imaging cancer.

Learn More

Upcoming Events

May

28–29

2024

Spring Stakeholder Meetings

Virtual

June

8–11

2024

SNMMI 2024 Annual Meeting

Toronto, Canada

Join us for Spring Stakeholder Meetings!

Isotope Product Catalog

DOE Isotope Program and QSA Global Inc. partner for domestic production of iridium-192

DOE Isotope Program Welcomes Texas A&M University Cyclotron Institute to the University Isotope Network

Announcing domestic supply of lead-203

Translating Research to Applications

Recordings Now Available: DOE IP Virtual Seminar Series

Medical Isotopes

Technical Resources

NIDC News

DOE Isotope Program Highlights

Transforming Cancer Diagnosis and Treatment with Cerium/Lanthanum-134

Scientists Identify an Alternative System for Producing the Medical Isotope Scandium-44

Capturing the Chemistry of Radium-223 for Cancer Treatment

Researchers Improve Production for Short-Lived Scandium Radioisotopes

Upcoming Events

Spring Stakeholder Meetings

SNMMI 2024 Annual Meeting

Recent Publications

Photonuclear production of 47Ca for 47Ca/47Sc generator from natural CaCO3 targets

Effective therapy with Bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor models

Evaluation of 177 Lu and 47 Sc Picaga-Linked, Prostate-Specific Membrane Antigen-Targeting Constructs for Their Radiotherapeutic Efficacy and Dosimetry